Full Name
Dr. Mary Ann Anderson MBBS, FRACP, FRCPA, PhD
Job Title
Consultant Haematologist
Company/Affiliation
The University of Melbourne
Speaker Bio
Dr. Mary Ann Anderson is an Associate Professor and has been a practicing clinical hematologist since 2012. She currently practices at both The Royal Melbourne Hospital and the Peter MacCallum Cancer Centre in Melbourne, where she leads the Low-Grade Lymphoma and Chronic Lymphocytic Leukemia Disease Stream. She is a foundation member of the CAR T consultant group at the Peter MacCallum Cancer Centre, having joined the team at the inception of the unit in 2019.
Dr. Anderson obtained her PhD from the University of Melbourne in 2017, where she undertook extensive clinical and laboratory studies of a novel approach to treating B-cell malignancies by harnessing apoptotic cell death with the agent now known as venetoclax. Since completing her PhD, Dr. Anderson has continued her studies into the mechanisms by which B-cell malignancies evade targeted agents and develop therapeutic resistance.
Dr. Anderson obtained her PhD from the University of Melbourne in 2017, where she undertook extensive clinical and laboratory studies of a novel approach to treating B-cell malignancies by harnessing apoptotic cell death with the agent now known as venetoclax. Since completing her PhD, Dr. Anderson has continued her studies into the mechanisms by which B-cell malignancies evade targeted agents and develop therapeutic resistance.
Speaking At
